Tag Archives: Timothy Ramey

Pivotal Research Thinks Constellation Brands Inc’s Stock is Going to Recover

Pivotal Research analyst Timothy Ramey maintained a Buy rating on Constellation Brands Inc (STZ – Research Report) today and set a price target of $265. The company’s shares opened today at $152.61, close to its 52-week low of $152.51. Ramey

Pivotal Research Thinks Brown-Forman B’s Stock is Going to Recover

In a report released today, Timothy Ramey from Pivotal Research reiterated a Buy rating on Brown-Forman B (BF.B – Research Report), with a price target of $65. The company’s shares closed yesterday at $46.66, close to its 52-week low of

Pivotal Research Maintains a Sell Rating on Tyson Foods (TSN)

Pivotal Research analyst Timothy Ramey maintained a Sell rating on Tyson Foods (TSN – Research Report) today and set a price target of $40. The company’s shares opened today at $59.05, close to its 52-week low of $56.79. According to

Pivotal Research Sticks to Its Sell Rating for Flowers Foods (FLO)

In a report released today, Timothy Ramey from Pivotal Research maintained a Sell rating on Flowers Foods (FLO – Research Report), with a price target of $16. The company’s shares opened today at $19.38. Ramey said: “We were delusional to

Analyst Explains Why They Upgraded Their Rating on Balchem Corp (BCPC)

In a report released today, Timothy Ramey from Pivotal Research upgraded Balchem Corp (BCPC – Research Report) to Buy, with a price target of $100. The company’s shares opened today at $96. Ramey said: “We are raising our Rating to

Pivotal Research Maintains Their Buy Rating on Post Holdings Inc (POST)

Pivotal Research analyst Timothy Ramey maintained a Buy rating on Post Holdings Inc (POST – Research Report) today and set a price target of $120. The company’s shares opened today at $89.32. Ramey commented: “We expect Adjusted EBITDA of $326